オピオイド市場：オピオイドの種類、投与方法、用途、エンドユーザー別-2025-2030年の世界予測

オピオイド市場は、2024年には108億8,000万米ドルとなり、2025年には114億4,000万米ドル、CAGR 5.24%で成長し、2030年には147億9,000万米ドルに達すると予測されています。

オピオイド市場は、進化する患者ニーズ、規制改革、先進研究開発の岐路に立っています。本分析では、市場の現状と将来性を探り、その軌道を形成し続ける極めて重要な要因に焦点を当てる。ここ数年、臨床現場や治療プロトコルの微妙な変化により、需要と供給のダイナミクスを徹底的に見直す必要が生じています。ヘルスケアプロバイダーや政策規制を含む市場参入企業は、効果的な疼痛管理という重要なニーズと、患者の安全性という広範な要請とのバランスを取るよう求められています。データ主導の意思決定が、治療、治療提供、リスク管理における革新の指針になりつつあります。この包括的なレビューでは、科学的進歩と経済的要因の相互作用を検証し、市場の複雑な状況を理解するための基礎を築きました。業界が複雑な社会的、規制的、技術的課題を乗り越えていくためには、エビデンスに基づく戦略に沿った投資が不可欠です。この市場概要では、オピオイド市場の全体像を明らかにするために、変革的なシフト、セグメンテーションの洞察、地域や企業固有のダイナミクスについて、より深く掘り下げるための舞台を用意しました。

オピオイド市場を再定義する変革的シフト

市場における最近の変革的シフトは、利害関係者のオピオイドに対する認識と関わり方を再定義しています。規制の枠組みの急速な変化と、患者中心の医療への新たな注目が、重要な再編成をもたらしました。従来の流通チャネルは技術統合によって最適化され、厳格な安全性プロトコルを維持しながら、高品質の製剤への迅速なアクセスを可能にしています。また、新たな調査により、オピオイドの広範な適用から、より的を絞った治療レジメンへのパラダイムシフトが推進されています。この進化は、臨床ガイドラインや患者層の変化に迅速に対応できる適応力のあるビジネスモデルの重要性を強調しています。これと並行して、業界の技術革新は治療効果とリスク管理のギャップを埋め続けています。経済的圧力と競合は、研究機関と製薬会社の協力を促進し、精密治療と個別化医療が主流となる未来を確固たるものにしています。このような適応策は、単に反応的なものではなく、長年にわたる市場の課題に対する積極的な対応です。科学研究の強化、患者モニタリングプロトコルの改善、デジタルヘルスケアソリューションの融合は、市場の効率性を増幅させ、コンプライアンスと倫理的慣行を強化しながら、治療法の進歩を確実に患者に届ける。

市場分析を形成する包括的なセグメンテーションの洞察

市場を詳細に調査すると、多面的なセグメンテーションの枠組みから得られる洞察が明らかになります。オピオイドの種類を考える場合、市場分析では天然オピオイド、半合成オピオイド、合成オピオイドを区別しています。天然オピオイドのカテゴリーでは、コデインとモルヒネを研究することにより、さらにニュアンスを深めています。一方、半合成オピオイドは、ヒドロコドンとオキシコドンに焦点を当てて分析しています。急速に発展している合成オピオイドは、フェンタニルやメタドンといった明確なサブカテゴリーによって特徴づけられています。化学的分類にとどまらず、カプセルや錠剤を含む経口投与が、筋肉内投与や静脈内投与といった非経口経路や、ますます採用されつつある経皮的アプローチと並んで重要な役割を果たしている投与様式にまで分析が及んでいます。用途別セグメンテーションでは、全身麻酔と局所麻酔に分類される麻酔や、急性・慢性両方の症状に対応する疼痛管理など、明確な臨床セグメントをさらに詳しく説明します。最後に、エンドユーザー分析では、クリニックと病院、在宅医療、研究機関などのヘルスケア施設のニュアンスを調査します。この多面的なセグメンテーションは、戦略的意思決定と経営計画の両方に役立つ詳細なビューを提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性および急性疼痛疾患の罹患率の上昇によりオピオイド薬の消費量が増加
    • オピオイド治療へのアクセスを向上させるヘルスケアインフラとサービスの拡大
    • 医薬品研究開発の拡大は、新たなオピオイドの導入に貢献します。
  • 抑制要因
    • オピオイド処方管理に伴う高コスト
  • 機会
    • 医療サービスが行き届いていない地域におけるオピオイド依存症のカウンセリングと治療のための遠隔医療サービスの拡大
    • オピオイド依存症回復支援とコミュニティとのつながりのためのモバイルアプリの開発
  • 課題
    • オピオイドの処方と流通を規制する厳格な規制
• 市場セグメンテーション分析
  • オピオイドの種類：効果的な鎮痛作用により天然オピオイドの採用が増加
  • 応用：急性および慢性疼痛の両方を管理するための疼痛管理におけるオピオイドの応用の増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 オピオイド市場オピオイドの種類別

• 天然オピオイド
  • コデイン
  • モルヒネ
• 半合成オピオイド
  • ヒドロコドン
  • オキシコドン
• 合成オピオイド
  • フェンタニル
  • メサドン

第7章 オピオイド市場投与方法別

• 経口投与
  • カプセル
  • タブレット
• 非経口投与
  • 筋肉内
  • 静脈内
• 経皮投与

第8章 オピオイド市場：用途別

• 麻酔
  • 全身麻酔
  • 局所麻酔
• 咳止め
• 疼痛管理
  • 急性疼痛
  • 慢性疼痛

第9章 オピオイド市場：エンドユーザー別

• ヘルスケア施設
  • クリニック
  • 病院
• 在宅ヘルスケア
• 調査機関

第10章 南北アメリカのオピオイド市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のオピオイド市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのオピオイド市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AbbVie Inc.
• Accord Healthcare, Ltd.
• Alkermes plc
• AmerisourceBergen Corporation
• Bristol Laboratories Limited
• Johnson Matthey Plc
• Mallinckrodt LLC
• Noramco, Inc.
• Omnica Laboratories
• Purdue Pharma L.P.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. OPIOIDS MARKET MULTI-CURRENCY
• FIGURE 2. OPIOIDS MARKET MULTI-LANGUAGE
• FIGURE 3. OPIOIDS MARKET RESEARCH PROCESS
• FIGURE 4. OPIOIDS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 17. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 19. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. OPIOIDS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 25. OPIOIDS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. OPIOIDS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPIOIDS MARKET DYNAMICS
• TABLE 7. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 84. CANADA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 85. CANADA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 86. CANADA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 87. CANADA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 88. CANADA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. CANADA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. CANADA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. CANADA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. CANADA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 93. CANADA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 94. CANADA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. CANADA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. MEXICO OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. MEXICO OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 103. MEXICO OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. MEXICO OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 105. MEXICO OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 106. MEXICO OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. MEXICO OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 113. UNITED STATES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. UNITED STATES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. UNITED STATES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. UNITED STATES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 117. UNITED STATES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 118. UNITED STATES OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. UNITED STATES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 120. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 124. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 130. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 134. AUSTRALIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 135. AUSTRALIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 136. AUSTRALIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 137. AUSTRALIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 138. AUSTRALIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 139. AUSTRALIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. AUSTRALIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. AUSTRALIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. AUSTRALIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 143. AUSTRALIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 144. AUSTRALIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. AUSTRALIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 146. CHINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 147. CHINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 148. CHINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 149. CHINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 150. CHINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. CHINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. CHINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 153. CHINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. CHINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 155. CHINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 156. CHINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. CHINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 158. INDIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 159. INDIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 160. INDIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 161. INDIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 162. INDIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. INDIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 164. INDIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 165. INDIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. INDIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 167. INDIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 168. INDIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. INDIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 170. INDONESIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 171. INDONESIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 172. INDONESIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 173. INDONESIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 174. INDONESIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. INDONESIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. INDONESIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 177. INDONESIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. INDONESIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 179. INDONESIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 180. INDONESIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. INDONESIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 182. JAPAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 183. JAPAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 184. JAPAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 185. JAPAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 186. JAPAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 187. JAPAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. JAPAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 189. JAPAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. JAPAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 191. JAPAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 192. JAPAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. JAPAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 194. MALAYSIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 195. MALAYSIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 196. MALAYSIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 197. MALAYSIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 198. MALAYSIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 199. MALAYSIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 200. MALAYSIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 201. MALAYSIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. MALAYSIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 203. MALAYSIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 204. MALAYSIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. MALAYSIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 206. PHILIPPINES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 207. PHILIPPINES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 208. PHILIPPINES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 209. PHILIPPINES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 210. PHILIPPINES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. PHILIPPINES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 212. PHILIPPINES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 213. PHILIPPINES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. PHILIPPINES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 215. PHILIPPINES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 216. PHILIPPINES OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. PHILIPPINES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 218. SINGAPORE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 219. SINGAPORE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 220. SINGAPORE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 221. SINGAPORE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 222. SINGAPORE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 223. SINGAPORE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 224. SINGAPORE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 225. SINGAPORE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. SINGAPORE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 227. SINGAPORE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 228. SINGAPORE OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. SINGAPORE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 230. SOUTH KOREA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 231. SOUTH KOREA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 232. SOUTH KOREA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 233. SOUTH KOREA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 234. SOUTH KOREA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH KOREA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH KOREA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH KOREA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH KOREA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 242. TAIWAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 243. TAIWAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 244. TAIWAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 245. TAIWAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 246. TAIWAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 247. TAIWAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 248. TAIWAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 249. TAIWAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. TAIWAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 251. TAIWAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 252. TAIWAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. TAIWAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 254. THAILAND OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 255. THAILAND OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 256. THAILAND OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 257. THAILAND OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 258. THAILAND OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 259. THAILAND OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 260. THAILAND OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 261. THAILAND OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. THAILAND OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 263. THAILAND OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 264. THAILAND OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. THAILAND OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 266. VIETNAM OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 267. VIETNAM OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 268. VIETNAM OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 269. VIETNAM OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 270. VIETNAM OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 271. VIETNAM OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 272. VIETNAM OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 273. VIETNAM OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. VIETNAM OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 275. VIETNAM OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 276. VIETNAM OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. VIETNAM OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 278. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 279. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 280. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 281. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 282. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 283. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 284. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 291. DENMARK OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 292. DENMARK OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 293. DENMARK OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 294. DENMARK OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 295. DENMARK OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 296. DENMARK OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 297. DENMARK OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 298. DENMARK OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 299. DENMARK OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 300. DENMARK OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 301. DENMARK OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. DENMARK OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 303. EGYPT OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 304. EGYPT OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 305. EGYPT OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 306. EGYPT OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 307. EGYPT OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 308. EGYPT OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 309. EGYPT OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 310. EGYPT OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 311. EGYPT OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 312. EGYPT OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 313. EGYPT OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 314. EGYPT OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 315. FINLAND OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 316. FINLAND OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 317. FINLAND OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 318. FINLAND OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 319. FINLAND OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 320. FINLAND OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 321. FINLAND OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 322. FINLAND OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 323. FINLAND OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 324. FINLAND OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 325. FINLAND OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 326. FINLAND OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 327. FRANCE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 328. FRANCE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 329. FRANCE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 330. FRANCE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 331. FRANCE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 332. FRANCE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 333. FRANCE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 334. FRANCE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 335. FRANCE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 336. FRANCE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 337. FRANCE OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 338. FRANCE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 339. GERMANY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 340. GERMANY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 341. GERMANY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 342. GERMANY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 343. GERMANY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 344. GERMANY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 345. GERMANY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 346. GERMANY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 347. GERMANY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 348. GERMANY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 349. GERMANY OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 350. GERMANY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 351. ISRAEL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 352. ISRAEL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 353. ISRAEL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 354. ISRAEL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 355. ISRAEL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 356. ISRAEL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 357. ISRAEL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 358. ISRAEL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 359. ISRAEL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 360. ISRAEL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 361. ISRAEL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 362. ISRAEL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 363. ITALY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 364. ITALY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 365. ITALY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 366. ITALY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 367. ITALY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 368. ITALY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 369. ITALY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 370. ITALY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 371. ITALY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
• TABLE 372. ITALY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 373. ITALY OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 374. ITALY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
• TABLE 375. NETHERLANDS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
• TABLE 376. NETHERLANDS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
• TABLE 377. NETHERLANDS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 378. NETHERLANDS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
• TABLE 379. NETHERLANDS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 380. NETHERLANDS O

The Opioids Market was valued at USD 10.88 billion in 2024 and is projected to grow to USD 11.44 billion in 2025, with a CAGR of 5.24%, reaching USD 14.79 billion by 2030.

The opioids market stands at a crossroads of evolving patient needs, regulatory reform, and advanced research and development. In this analysis, we explore the market's current state and future potential, highlighting the pivotal factors that continue to shape its trajectory. Over the past few years, nuances in clinical practices and treatment protocols have necessitated a thorough reexamination of both supply and demand dynamics. Market participants, including healthcare providers and policy regulators, are being urged to balance the critical need for effective pain management with the broader imperative of patient safety. Increasingly, data-driven decisions are guiding innovations in therapy, treatment delivery, and risk management. This comprehensive review lays the groundwork for understanding the market's intricate landscape, examining the interplay between scientific progress and economic factors. As the industry navigates complex social, regulatory, and technical challenges, it is essential to align investment with evidenced-based strategies. This overview sets the stage for a deeper dive into transformative shifts, segmentation insights, and regional and company-specific dynamics that provide a holistic picture of the opioids market.

Transformative Shifts Redefining the Opioids Market

Recent transformative shifts in the market have redefined how stakeholders perceive and engage with opioids. Rapid changes in regulatory frameworks and a renewed focus on patient-centric care have led to significant realignments. Traditional distribution channels are being optimized through technological integration, enabling faster access to high-quality formulations while maintaining stringent safety protocols. Emerging research is driving a paradigm shift from broad-spectrum opioid applications to more targeted treatment regimens. This evolution underscores the importance of adaptive business models that can swiftly respond to changing clinical guidelines and patient demographics. In parallel, industry innovation continues to bridge the gap between therapeutic efficacy and risk management. Economic pressures and competitive forces are fostering collaborations between research institutions and pharmaceutical companies, cementing a future where precision therapies and personalized medicine dominate. Such adaptive measures are not simply reactive; they are proactive responses to long-standing market challenges. The convergence of enhanced scientific research, improved patient monitoring protocols, and digital healthcare solutions has amplified market efficiency, ensuring that therapeutic advances reach the patient while reinforcing compliance and ethical practices.

Comprehensive Segmentation Insights Shaping Market Analysis

A detailed examination of the market reveals insights that stem from a multi-faceted segmentation framework. When considering opioid types, the market analysis distinguishes among natural opiates, semi-synthetic opioids, and synthetic opioids. The natural opiates category is further nuanced by its study of codeine and morphine, whereas semi-synthetic opioids are dissected with a focus on hydrocodone and oxycodone. Synthetic opioids, a rapidly evolving segment, are characterized by distinct subcategories such as fentanyl and methadone. Beyond the chemical classification, the analysis extends to modes of administration, where oral delivery including capsules and tablets plays a significant role alongside parenteral routes like intramuscular and intravenous methods, and the increasingly adopted transdermal approaches. Application-based segmentation further elaborates distinct clinical segments such as anesthesia, which is methodically divided into general and regional anesthesia, and pain management, which addresses both acute and chronic conditions. Finally, an end-user analysis investigates the nuances among healthcare facilities, noted for their dual focus on clinics and hospitals, home healthcare, and research institutes. This multifaceted segmentation provides a granular view that informs both strategic decision-making and operational planning.

Based on Opioid Types, market is studied across Natural Opiates, Semi-Synthetic Opioids, and Synthetic Opioids. The Natural Opiates is further studied across Codeine and Morphine. The Semi-Synthetic Opioids is further studied across Hydrocodone and Oxycodone. The Synthetic Opioids is further studied across Fentanyl and Methadone.

Based on Mode of Administration, market is studied across Oral Administration, Parenteral Administration, and Transdermal Administration. The Oral Administration is further studied across Capsules and Tablets. The Parenteral Administration is further studied across Intramuscular and Intravenous.

Based on Application, market is studied across Anesthesia, Cough Suppression, and Pain Management. The Anesthesia is further studied across General Anesthesia and Regional Anesthesia. The Pain Management is further studied across Acute Pain and Chronic Pain.

Based on End-User, market is studied across Healthcare Facilities, Home Healthcare, and Research Institutes. The Healthcare Facilities is further studied across Clinics and Hospitals.

Key Regional Dynamics Influencing Market Growth

The opioids market exhibits distinct regional characteristics driven by varied economic, regulatory, and healthcare factors. In the Americas, the market is influenced by robust healthcare systems and evolving policies that emphasize patient safety and innovation. Concurrently, regions spanning Europe, the Middle East, and Africa experience a blend of stringent regulatory oversight coupled with dynamic market opportunities, as diverse healthcare systems adapt to emerging treatment protocols. Meanwhile, Asia-Pacific stands out with its rapidly expanding pharmaceutical industries, heightened research capabilities, and significant investments in healthcare infrastructure. These regions collectively demonstrate unique growth trajectories, challenges, and opportunities that influence market behavior at both a macro and micro level. The interplay among these regions highlights the need for localized strategies that account for cultural, economic, and regulatory differences. As countries balance modernization with legacy systems, investors and key stakeholders are provided with a rich tapestry of market insights that underscore the importance of both global collaboration and regional specialization in achieving competitive advantage.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Innovation in the Opioids Market

The competitive landscape in the opioids market is marked by the strategic initiatives of several key industry leaders. Major players such as Abbott Laboratories and AbbVie Inc. are continuously refining their research and development processes to pioneer advanced therapeutic solutions. Companies like Accord Healthcare, Ltd. and Alkermes plc have initiated strategic collaborations to enhance both drug efficacy and safety profiles. Globally recognized entities, including AmerisourceBergen Corporation and Bristol Laboratories Limited, contribute to market dynamism by streamlining supply chains and adopting innovative distribution models. This landscape is further enriched by the initiatives of Johnson Matthey Plc, Mallinckrodt LLC, and Noramco, Inc., which are instrumental in translating research breakthroughs into marketable solutions. Omnica Laboratories, Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. round out the competitive narrative by emphasizing quality, compliance, and next-generation innovations. Through continuous investment in technology and research, these companies are shaping the future of the industry, undertaking rigorous measures to balance market growth with patient-centered care and global safety standards.

The report delves into recent significant developments in the Opioids Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Accord Healthcare, Ltd., Alkermes plc, AmerisourceBergen Corporation, Bristol Laboratories Limited, Johnson Matthey Plc, Mallinckrodt LLC, Noramco, Inc., Omnica Laboratories, Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a proactive stance in navigating the complexities of the opioids market. It is imperative to invest in research and development initiatives that promote the creation of safer and more effective opioid formulations. Companies should focus on strengthening their quality assurance measures and expanding their portfolio through strategic partnerships and acquisitions. Embracing digital transformation can further streamline production, distribution, and patient monitoring processes, ensuring that innovations are rapidly integrated into clinical practice. In addition, fostering open collaboration with regulatory bodies will facilitate smoother market entry and sustained growth. It is also recommended that decision-makers prioritize market education and transparent communication strategies to build trust among stakeholders. These strategic interventions should be paired with robust risk management practices to mitigate potential liabilities. Emphasizing continuous improvement through feedback loops from clinical outcomes and market performance will empower companies to adapt in real time, ensuring they remain competitive in a swiftly evolving marketplace.

Conclusion and Forward-Looking Perspectives

In conclusion, the analysis of the opioids market provides a deep and insightful perspective into a sector that is critical to modern healthcare. The evolving dynamics, driven by both external regulatory pressures and internal innovation, are crafting a future that prioritizes patient safety, quality care, and scientific advancement. By dissecting the market through detailed segmentation and regional analysis, this review underscores the importance of a balanced approach that integrates clinical expertise with market intelligence. The competitive landscape, shaped by leading industry players, further highlights the necessity for agile strategies in the face of emerging challenges. As the market continues to evolve, stakeholders are urged to maintain a forward-looking perspective that embraces change and leverages data-driven insights for sustainable growth. This comprehensive review offers not just a summary of current trends, but a roadmap for navigating future opportunities in a complex and vital market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic and acute pain conditions drives up opioid medication consumption
    • 5.1.1.2. Expansion of healthcare infrastructure and services enhancing accessibility to opioid treatments
    • 5.1.1.3. Expanding pharmaceutical research and development contributes to the introduction of new opioids
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with opioid prescription management
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding telehealth services for opioid addiction counseling and treatment in underserved areas
    • 5.1.3.2. Developing mobile apps for opioid addiction recovery support and community connectivity
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations to control the prescription and distribution of opioids
• 5.2. Market Segmentation Analysis
  • 5.2.1. Opioid Types: Rising adoption of natural opiates due to their effective pain-relieving properties
  • 5.2.2. Application: Rising application of opioids in pain management to manage both acute and chronic pain conditions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Opioids Market, by Opioid Types

• 6.1. Introduction
• 6.2. Natural Opiates
  • 6.2.1. Codeine
  • 6.2.2. Morphine
• 6.3. Semi-Synthetic Opioids
  • 6.3.1. Hydrocodone
  • 6.3.2. Oxycodone
• 6.4. Synthetic Opioids
  • 6.4.1. Fentanyl
  • 6.4.2. Methadone

7. Opioids Market, by Mode of Administration

• 7.1. Introduction
• 7.2. Oral Administration
  • 7.2.1. Capsules
  • 7.2.2. Tablets
• 7.3. Parenteral Administration
  • 7.3.1. Intramuscular
  • 7.3.2. Intravenous
• 7.4. Transdermal Administration

8. Opioids Market, by Application

• 8.1. Introduction
• 8.2. Anesthesia
  • 8.2.1. General Anesthesia
  • 8.2.2. Regional Anesthesia
• 8.3. Cough Suppression
• 8.4. Pain Management
  • 8.4.1. Acute Pain
  • 8.4.2. Chronic Pain

9. Opioids Market, by End-User

• 9.1. Introduction
• 9.2. Healthcare Facilities
  • 9.2.1. Clinics
  • 9.2.2. Hospitals
• 9.3. Home Healthcare
• 9.4. Research Institutes

10. Americas Opioids Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Opioids Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Opioids Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2024
• 13.2. FPNV Positioning Matrix, 2024
• 13.3. Competitive Scenario Analysis
  • 13.3.1. ANANDA Scientific announces a clinical trial evaluating Nantheia ATL5, in the treatment of co-occurring Opioid Use
  • 13.3.2. FDA approval of over-the-counter naloxone nasal spray by Amneal set to transform opioid overdose intervention accessibility
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AbbVie Inc.
• 3. Accord Healthcare, Ltd.
• 4. Alkermes plc
• 5. AmerisourceBergen Corporation
• 6. Bristol Laboratories Limited
• 7. Johnson Matthey Plc
• 8. Mallinckrodt LLC
• 9. Noramco, Inc.
• 10. Omnica Laboratories
• 11. Purdue Pharma L.P.
• 12. Sun Pharmaceutical Industries Ltd.
• 13. Teva Pharmaceutical Industries Ltd.
• 14. Viatris Inc.